Skip to main content
Log in

Critical Neurological Conditions: Severe Toxic Polyneuropathy with the Development of Respiratory Failure and Rhabdomyolysis

  • Published:
Human Physiology Aims and scope Submit manuscript

Abstract

The article describes the clinical case of severe toxic polyneuropathy due to a confirmed exogenous intoxication with amphetamine in a 52-year-old man. The clinical picture included muscle weakness in several muscle groups (neck, back, arms, legs, and respiratory muscles), respiratory failure (requiring mechanical ventilation), rhabdomyolysis, mild nephropathy, and liver cytolysis. Differential diagnosis was made between myasthenia gravis, myopathy, and amyotrophic lateral sclerosis. A course of intensive therapy led to almost complete regression of signs and symptoms and improved the electroneuromyographic pattern. An immunochromatographic urine drug screen was performed in view of the rapid partial regression of signs and symptoms and results of a neurophysiological study; the patient tested positive for amphetamine. The clinical case demonstrates rare complications of amphetamine use, which should be kept in mind during a diagnostic search.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. The Main Indicators of the Narcological Service in the Russian Federation in 2014—2015: Statistical Sourcebook, Moscow, 2016.

  2. Fedorov, G.V., Counteraction to illegal circulation of narcotic drugs, psychotropic substances and their precursors among minors and youth, Vestn. Polotsk. Gos. Univ., Ser. D: Ekonomic. Yuridic. Nauki, 2009, no. 10, p. 211.

  3. Shanin, I.A., Khan, O.Yu., and Petukhov, A.E., Detection of amphetamines in urine using immunochromatographic test strips, Sud.-Med. Ekspert., 2012, vol. 55, no. 4, p. 33.

    CAS  Google Scholar 

  4. Beck, O., Kraft, M. Moeller, M.R., et al., Frontline immunochromatographic device for on-site urine testing of amphetamines: laboratory validation using authentic specimens, Ann. Clin. Biochem., 2000, vol. 37, no. 2, p. 199. https://doi.org/10.1258/0004563001899005

    Article  CAS  Google Scholar 

  5. Connell, P.H., Clinical manifestations and treatment of amphetamine type of dependence, JAMA, 1966, vol. 196, p. 718.

    Article  Google Scholar 

  6. Albertson, T.E., Walby, W.F., and Derlet, R.W., Stimulant-induced pulmonary toxicity, Chest, 1995, vol. 108, p. 1140.

    Article  CAS  Google Scholar 

  7. Pothos, E.N., Creese, I., and Hoebell, B.G., Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intake, J. Neurosci., 1995, vol. 75, no. 10, p. 6640.

    Article  Google Scholar 

  8. Koren’, E.V. and Kupriyanova, T.A., Hyperkinetic Disorders (ADHD): Clinical Recommendations, Moscow; 2015.

    Google Scholar 

  9. Crisostomo, E.A., Duncan, P.W., Propst, M., et al., Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients, Ann. Neurol., 1988. https://doi.org/10.1002/ana.410230117

  10. Connell, P.H., Amphetamine psychosis, Br. Med. J., 1957, vol. 1, p. 582.

    Article  Google Scholar 

  11. Parkes, J.D. and Fenton, G.W., Levo(–) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy, J. Neurol. Neurosurg. Psychiatry, 1973, vol. 36, p. 1076.

    Article  CAS  Google Scholar 

  12. Albertson, T.E., Derlet, R.W., and Van Hoozen, B.E., Methamphetamine and the expanding complications of amphetamines, West. J. Med., 1999, vol. 170, p. 214.

    CAS  Google Scholar 

  13. Garwood, E.R., Bekele, W., McCulloch, C.E., and Christine, C.W., Amphetamine exposure is elevated in Parkinson’s disease, Neurotoxicology, 2006, vol. 27, p. 1003. https://doi.org/10.1016/j.neuro.2006.03.015

    Article  CAS  Google Scholar 

  14. Curtin, K., Fleckenstein, A.E., Robison, R.J., et al., Methamphetamine/amphetamine abuse and risk of Parkinson’s disease in Utah: a population-based assessment, Drug Alcohol Depend., 2015, vol. 146, p. 30. https://doi.org/10.1016/j.drugalcdep.2014.10.027

  15. Stafford, C.R., Bogdanoff, B.M., Green, L., and Spector, H.B., Mononeuropathy multiplex as a complication of amphetamine angiitis, Neurology, 1975, vol. 25, p. 570.

    Article  CAS  Google Scholar 

  16. Citron, B.P., Halpern, M., McCarron, M., et al., Necrotizing angiitis associated with drug abuse, N. Engl. J. Med., 1970, vol. 283, p. 1003. https://doi.org/10.1056/NEJM197011052831901

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yu. V. Ryabinkina.

Ethics declarations

Conflict of interests. The authors declare that they have no conflict of interest.

This article does not contain any studies involving human subjects performed by any of the authors.

Additional information

Translated by T. Tkacheva

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ryabinkina, Y.V., Zakharova, M.N., Polishchuk, R.V. et al. Critical Neurological Conditions: Severe Toxic Polyneuropathy with the Development of Respiratory Failure and Rhabdomyolysis. Hum Physiol 48, 952–955 (2022). https://doi.org/10.1134/S0362119722080114

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0362119722080114

Keywords:

Navigation